E
EyeBio
Biotech & Life Sciences · London, United Kingdom · Founded 2021 Unicorn
Investors
8 investors on EyeBio's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Global footprint
Where EyeBio has talent and traffic
team presence
across markets
Patent intelligence
$1.7B patent portfolio · 1,993 active families
Where EyeBio concentrates vs peers
Each axis is a top-10 topic across EyeBio and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about EyeBio
An AI-synthesized read of the highest-engagement posts about EyeBio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See EyeBio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.